Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Acq. announced Inv. presentation Quarterly results Appointed director CC transcript Auditor change Director departure
|
JUNIPER PHARMACEUTICALS INC (JNP)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/31/2018 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)]: |
08/31/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/31/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/31/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/31/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/31/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/31/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/31/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/31/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/31/2018 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
08/15/2018 |
4
| GERAGHTY JAMES A (Director) has filed a Form 4 on JUNIPER PHARMACEUTICALS INC
Txns:
| Disposed/sold 80,747 shares
@ $11.5, valued at
$928.6k
Disposed/sold 30,000 options to buy
@ $5.15, valued at
$154.5k
Disposed/sold 70,000 options to buy
@ $7.51, valued at
$525.7k
|
|
08/15/2018 |
4
| Csimma Cristina (Director) has filed a Form 4 on JUNIPER PHARMACEUTICALS INC
Txns:
| Disposed/sold 36,109 shares
@ $11.5, valued at
$415.3k
|
|
08/15/2018 |
4
| GOOD JENNIFER L (Director) has filed a Form 4 on JUNIPER PHARMACEUTICALS INC
Txns:
| Disposed/sold 15,000 shares
@ $11.5, valued at
$172.5k
|
|
08/15/2018 |
4
| GRAY MARY ANN (Director) has filed a Form 4 on JUNIPER PHARMACEUTICALS INC
Txns:
| Disposed/sold 16,244 shares
@ $11.5, valued at
$186.8k
|
|
08/15/2018 |
4
| MERRIFIELD C ANN (Director) has filed a Form 4 on JUNIPER PHARMACEUTICALS INC
Txns:
| Disposed/sold 24,103 shares
@ $11.5, valued at
$277.2k
|
|
08/15/2018 |
4
| MESSINA RICHARD (Director) has filed a Form 4 on JUNIPER PHARMACEUTICALS INC
Txns:
| Disposed/sold 13,657 shares
@ $11.5, valued at
$157.1k
Disposed/sold 250 shares
@ $11.5, valued at
$2.9k
Disposed/sold 250 shares
@ $11.5, valued at
$2.9k
Disposed/sold 250 shares
@ $11.5, valued at
$2.9k
Disposed/sold 8,000 shares
@ $11.5, valued at
$92k
Disposed/sold 9,700 shares
@ $11.5, valued at
$111.6k
Disposed/sold 41,000 shares
@ $11.5, valued at
$471.5k
Disposed/sold 14,500 shares
@ $11.5, valued at
$166.8k
Disposed/sold 2,001 shares
@ $11.5, valued at
$23k
Disposed/sold 28,000 shares
@ $11.5, valued at
$322k
Disposed/sold 6,250 shares
@ $11.5, valued at
$71.9k
|
|
08/15/2018 |
4
| Patel Nikin (COO) has filed a Form 4 on JUNIPER PHARMACEUTICALS INC
Txns:
| Paid exercise price by delivering 123,823 shares
@ $11.5, valued at
$1.4M
Granted 10,500 shares
@ $11.5, valued at
$120.8k
Exercised 40,000 options to buy
@ $7.9, valued at
$316k
Exercised 10,000 options to buy
@ $4.05, valued at
$40.5k
Exercised 53,000 options to buy
@ $5.15, valued at
$273k
Exercised 50,000 options to buy
@ $7.82, valued at
$391k
Exercised 32,000 options to buy
@ $5.56, valued at
$177.9k
Exercised 32,000 options to buy
@ $7.05, valued at
$225.6k
|
|
08/15/2018 |
4
| Secor Alicia (President and CEO) has filed a Form 4 on JUNIPER PHARMACEUTICALS INC
Txns:
| Disposed/sold 103,855 shares
@ $11.5, valued at
$1.2M
Disposed/sold 110,000 options to buy
@ $7.9, valued at
$869k
Disposed/sold 127,500 options to buy
@ $5.15, valued at
$656.6k
Disposed/sold 225,000 options to buy
@ $7.59, valued at
$1.7M
|
|
08/15/2018 |
4
| Young Jeffrey E (CFO) has filed a Form 4 on JUNIPER PHARMACEUTICALS INC
Txns:
| Disposed/sold 30,413 shares
@ $11.5, valued at
$349.7k
Disposed/sold 40,000 options to buy
@ $7.9, valued at
$316k
Disposed/sold 170,000 options to buy
@ $5.6, valued at
$952k
|
|
08/15/2018 |
3
| Catalent, Inc. (10% Owner) has filed a Form 3 on JUNIPER PHARMACEUTICALS INC |
08/14/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
08/14/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
08/14/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
08/14/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
08/14/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
08/14/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
08/14/2018 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
08/14/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
08/14/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
08/14/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
08/14/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
08/14/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
08/14/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
08/14/2018 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement: |
|
|
|